Clinical and functional characteristics of co-occurring cerebral palsy and autism spectrum disorder among children and young adults / Myriam CASSEUS in Research in Autism Spectrum Disorders, 118 (October 2024)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 118 (October 2024) . - 102490 Titre : Clinical and functional characteristics of co-occurring cerebral palsy and autism spectrum disorder among children and young adults Type de document : Texte imprimé et/ou numérique Auteurs : Myriam CASSEUS, Auteur ; Hannah A. SHOVAL, Auteur ; Abby J. ERASMUS, Auteur ; JenFu CHENG, Auteur Article en page(s) : 102490 Langues : Anglais (eng) Mots-clés : Cerebral palsy  Autism spectrum disorder  Co-occurring CP+ASD  Neurodevelopmental disorders  Pediatric CP Index. décimale : PER Périodiques Résumé : Background To examine clinical and functional factors associated with co-occurring cerebral palsy (CP) and autism spectrum disorder (ASD). Methods Data were collected from the electronic health records of 994 patients with CP aged 3 to 26 years (59 % males) who received services from a U.S. hospital system between January 1, 2016 and July 1, 2021. CP, ASD, and other co-occurring conditions were abstracted using International Classification of Diseases - 10th Revision (ICD-10) codes, diagnostic summaries, and clinical descriptions. Bivariate and adjusted multivariable analyses examined the association between ASD, CP type, Gross Motor Function Classification System (GMFCS) level, speech or language disorders, and mental or behavioral problems. Results Prevalence of ASD was 8.2 % among patients with CP. Patients with GMFCS levels III-V were less likely to have a diagnosis of ASD (adjusted odds ratio [AOR] = 0.21; 95 % confidence interval [CI], 0.11-0.41). However, speech or language disorders (AOR = 6.00; 95 % CI, 2.14-16.81) and mental or behavioral problems (AOR =8.79; 95 % CI, 4.99-15.49) were associated with significantly higher odds of ASD. Conclusions Children and young adults with co-occurring CP and ASD have higher prevalence of clinical and functional impairments compared with counterparts with CP without co-occurring ASD. Screening for both conditions is necessary because of the high prevalence of ASD in this population. It is also necessary to implement specialized assessment procedures to decrease the risk of misclassifying or overlooking ASD among children and young adults with CP. En ligne : https://doi.org/10.1016/j.rasd.2024.102490 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=540 [article] Clinical and functional characteristics of co-occurring cerebral palsy and autism spectrum disorder among children and young adults [Texte imprimé et/ou numérique] / Myriam CASSEUS, Auteur ; Hannah A. SHOVAL, Auteur ; Abby J. ERASMUS, Auteur ; JenFu CHENG, Auteur . - 102490. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 118 (October 2024) . - 102490 Mots-clés : Cerebral palsy  Autism spectrum disorder  Co-occurring CP+ASD  Neurodevelopmental disorders  Pediatric CP Index. décimale : PER Périodiques Résumé : Background To examine clinical and functional factors associated with co-occurring cerebral palsy (CP) and autism spectrum disorder (ASD). Methods Data were collected from the electronic health records of 994 patients with CP aged 3 to 26 years (59 % males) who received services from a U.S. hospital system between January 1, 2016 and July 1, 2021. CP, ASD, and other co-occurring conditions were abstracted using International Classification of Diseases - 10th Revision (ICD-10) codes, diagnostic summaries, and clinical descriptions. Bivariate and adjusted multivariable analyses examined the association between ASD, CP type, Gross Motor Function Classification System (GMFCS) level, speech or language disorders, and mental or behavioral problems. Results Prevalence of ASD was 8.2 % among patients with CP. Patients with GMFCS levels III-V were less likely to have a diagnosis of ASD (adjusted odds ratio [AOR] = 0.21; 95 % confidence interval [CI], 0.11-0.41). However, speech or language disorders (AOR = 6.00; 95 % CI, 2.14-16.81) and mental or behavioral problems (AOR =8.79; 95 % CI, 4.99-15.49) were associated with significantly higher odds of ASD. Conclusions Children and young adults with co-occurring CP and ASD have higher prevalence of clinical and functional impairments compared with counterparts with CP without co-occurring ASD. Screening for both conditions is necessary because of the high prevalence of ASD in this population. It is also necessary to implement specialized assessment procedures to decrease the risk of misclassifying or overlooking ASD among children and young adults with CP. En ligne : https://doi.org/10.1016/j.rasd.2024.102490 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=540

Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study / Myriam CASSEUS in Autism Research, 16-4 (April 2023)  

Public ISBD [article]  inAutism Research > 16-4 (April 2023) . - p.855-867 Titre : Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study Type de document : Texte imprimé et/ou numérique Auteurs : Myriam CASSEUS, Auteur ; Wun Jung KIM, Auteur ; Daniel B. HORTON, Auteur Article en page(s) : p.855-867 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Abstract There is a lack of nationally representative studies examining the co-occurrence of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children. This study examines comorbid mental, behavioral, and developmental disorders (MBDDs) and associated treatment modalities for children with co-occurring ASD and ADHD. Cross-sectional analyses were conducted using data from the pooled 2016-2018 National Survey of Children's Health (sample n = 102,341). Nationally representative prevalences were estimated for sociodemographic variables, comorbidities, psychotropic medication, and behavioral treatment. We assessed multivariable associations between co-occurring ASD?+?ADHD and MBDDs, use of psychotropic medication, and receipt of behavioral treatment after adjustment for sociodemographic confounders. Compared to children with ASD without co-occurring ADHD, children with ASD?+?ADHD had higher prevalence of most MBDDs, including anxiety (AOR 4.03 [95% CI 2.77, 4.87]), depression (AOR 3.08 [95% CI 1.77, 5.36]), behavior or conduct problems (AOR 4.06 [95% CI 2.72, 6.06]), and other mental health conditions. Similarly, compared to children with ADHD without ASD, children with ASD?+?ADHD had higher odds of anxiety (AOR 3.49 [95% CI 2.65, 4.61]), depression (AOR 1.67 [95% CI 1.21, 2.29]), behavior or conduct problems (AOR 2.31 [95% CI 1.68, 3.17]), and other mental health conditions. Children with ASD?+?ADHD were significantly more likely to take psychotropic medication than children with ASD without ADHD. Among children with ASD?+?ADHD, males had higher odds of receiving behavioral treatment, whereas older children and adolescents were more likely to take psychotropic medication. A multidisciplinary approach is necessary to support the complex needs of these children. En ligne : https://doi.org/10.1002/aur.2894 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=499 [article] Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study [Texte imprimé et/ou numérique] / Myriam CASSEUS, Auteur ; Wun Jung KIM, Auteur ; Daniel B. HORTON, Auteur . - p.855-867. Langues : Anglais (eng) in Autism Research > 16-4 (April 2023) . - p.855-867 Index. décimale : PER Périodiques Résumé : Abstract There is a lack of nationally representative studies examining the co-occurrence of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children. This study examines comorbid mental, behavioral, and developmental disorders (MBDDs) and associated treatment modalities for children with co-occurring ASD and ADHD. Cross-sectional analyses were conducted using data from the pooled 2016-2018 National Survey of Children's Health (sample n = 102,341). Nationally representative prevalences were estimated for sociodemographic variables, comorbidities, psychotropic medication, and behavioral treatment. We assessed multivariable associations between co-occurring ASD?+?ADHD and MBDDs, use of psychotropic medication, and receipt of behavioral treatment after adjustment for sociodemographic confounders. Compared to children with ASD without co-occurring ADHD, children with ASD?+?ADHD had higher prevalence of most MBDDs, including anxiety (AOR 4.03 [95% CI 2.77, 4.87]), depression (AOR 3.08 [95% CI 1.77, 5.36]), behavior or conduct problems (AOR 4.06 [95% CI 2.72, 6.06]), and other mental health conditions. Similarly, compared to children with ADHD without ASD, children with ASD?+?ADHD had higher odds of anxiety (AOR 3.49 [95% CI 2.65, 4.61]), depression (AOR 1.67 [95% CI 1.21, 2.29]), behavior or conduct problems (AOR 2.31 [95% CI 1.68, 3.17]), and other mental health conditions. Children with ASD?+?ADHD were significantly more likely to take psychotropic medication than children with ASD without ADHD. Among children with ASD?+?ADHD, males had higher odds of receiving behavioral treatment, whereas older children and adolescents were more likely to take psychotropic medication. A multidisciplinary approach is necessary to support the complex needs of these children. En ligne : https://doi.org/10.1002/aur.2894 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=499

---

1 (1 - 2 / 2)